INDIA CATHETERS MARKET ANALYSIS

India catheters market is estimated to be valued at US$ 858.5 million in 2023 and is expected to exhibit a CAGR of 17.3% during the forecast period (2023-2030).

Analysts’ Views on India Catheters Market:

Over the forecast period, the prevalence of chronic diseases including cancer, cardiovascular disease (CVD), diabetes, and others is anticipated to rise, as is the elderly population, which tends to raise hospitalization rates as a result of the increase in chronic diseases. For instance, in June 2022, according to the World Health Organization, in India, there are estimated 77 million people above the age of 18 years suffering from diabetes (type 2) and nearly 25 million are prediabetics (at a higher risk of developing diabetes in near future). More than 50% of people are unaware of their diabetic status which leads to health complications if not detected and treated early.

Figure 1. India Catheters Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2030

To learn more about this report, request sample copy

Figure 2. India Catheters Market Share (%), By Type, 2023

To learn more about this report, request sample copy

India Catheters Market– Drivers

Rising prevalence of urological diseases

Rising prevalence of urological diseases leads to the use of urological catheters to prevent urological diseases is expected to the growth of the India catheters market over the forecast period. For instance, in October 2021, according to an article published by the VeryWell Health, a Foley catheter is an indwelling urinary catheter for the prevention of urological diseases and when a Foley is in place, excellent hygiene is essential for preventing a urinary tract infection (UTI). The portion of the tube that touches the body should be thoroughly cleaned during bath time and any time it is soiled. In addition, special soaps or cleansers may be used on the genitals to minimize the risk of infection after surgery.

Increasing geriatric population

Increasing the geriatric population in India is expected to have chronic diseases and this is attributed to driving the market over the forecast period. For instance, in July 2020, as per data from Population Projections for India and States, a report published by the National Commission on Population, the 2020 National Commission on Population report estimates that there will be nearly 138 million elderly persons in India in 2021, comprising 67 million males and 71 million females and the growth rate of the elderly population is higher than that of the general population.

India Catheters Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the India catheters market owing to the increase in hospitalizations caused due to the COVID-19 as well as chronic diseases. As governments and healthcare institutions were found to increase efficient medical treatment to treat COVID-19 patients, the usage of catheters witnessed tremendous demand in hospitals and emergency clinics. Patients with suspected or confirmed diagnoses of COVID-19 were being treated with the help of catheters, and hence, the demand for these products remained huge throughout the pandemic. Moreover, product launches amid the pandemic were also anticipated to have a positive impact on the market’s growth. For instance, on January 06, 2023, according to an article published in the journal of BioMed Central Infectious Diseases, the rates of the following nosocomial infections were compared at pre- and post-pandemic period: ventilator-associated pneumonia (VAP), central line associated blood stream infection (CLABSI), catheter-associated urinary tract infections (CAUTI) and incidence of multiple drug resistance (MDR) pathogens. This study investigated the CLABSI and CAUTI, prevalence and admission during the covid-19 increases.

India Catheters Market- Segmentation

The India catheters market report is segmented into type and end user.

Among Type, the India catheters market is segmented into cardiovascular catheters, urology catheters, intravenous catheters, neurovascular catheters, and specialty catheters. Out of which, the intravenous segment is expected to dominate the market during the forecast period and this is attributed due to the increasing prevalence of surgeries in India due to an increase in chronic diseases.

Among End User, the India catheters market is segmented into hospitals, diagnostic centers, specialty clinics, long term care facilities, and others. The hospital segment is expected to dominate the market over the forecast period owing to the rise in prevalence of chronic diseases which tends to the increase in the hospitalization rate for the treatment of chronic diseases.

Among all segmentation, the intravenous segment has the highest potential due to the increasing prevalence of surgeries in India due to the increase in chronic diseases over the forecast period. For instance, in July 2022, B. Braun SE, a medical and pharmaceutical device company, announced the launch of its new Introcan Safety 2 IV (intravenous) Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and exposure to blood.

India Catheters Market- Key Developments

In September 2021, Medtronic, the global company in medical technology, announced it has received Conformité Européenne (CE) mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist 079 radial access guide catheter—the first catheter specifically designed for the unique demands of accessing the neurovasculature to treat stroke, brain aneurysms, and other conditions through the radial artery versus access through the transfemoral artery.

On April 12, 2023, BACTIGUARD AB,  a global medtech company with a purpose to prevent infections announced the launch of a clinical study to gain additional clinical evidence of the efficacy of central venous catheters with Bactiguard’s infection prevention coating technology (BIP CVC) as compared with a non-coated standard catheter. The endpoints of the study will include, among others, catheter-associated bloodstream infections and thrombosis rates. The study will be performed at multiple sites in India and is under the supervision of primary investigator Dr. Yatin Metha, Medanta Hospital in New Dehli. The study has been approved by the local regulatory authorities DCGI (Drug Controller General of India).

In May 2020, Cook, a global medical device company, and Surmodics, Inc., a provider of surface modification, drug delivery, and in vitro diagnostic technologies to the healthcare industry announced an agreement in which Cook will distribute two new Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that can be used over 0.014-inch and a 0.018-inch wire guides.

In January 2022, ICU Medical Inc., a developer, manufacturer, and seller of medical products used in infusion therapy, vascular access, and vital care applications announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately US$ 2.5 billion.

India Catheters Market- Key Trends

Increase healthcare expenditure

Increase in healthcare expenditure by the government of India is expected to boost the India catheter market over the forecast period. For instance, in September 2022, according to the International Trade Administration of the U.S. Department of Commerce, the Indian healthcare industry reached US$ 190 billion in 2020, and, according to the India Brand Equity Foundation, it is expected to reach US$ 370 billion by 2024-2025. This increase is due to the growing demand for specialized and higher-quality healthcare facilities. The products and services driving this growth include hospitals, medical devices, clinical trials, telemedicine, medical tourism, health insurance, and medical equipment. The industry’s rapid development is fueled by large investments from existing corporate hospital chains and new entrants backed by private equity investors.

India Catheters Market: Restraints

Risk of catheter-associated infections

Risk of catheter-associated infections such as urinary tract infection (UTI) involving any part of the urinary system, including urethra, bladder, ureters, and kidney is expected to hinder the market growth over the forecast period. So, catheters should only be used for appropriate indications and should be removed as soon as they are no longer needed. For instance, in October 2020, according to the Centers for Diseases Control and Prevention (CDC), UTIs are the most common type of healthcare-associated infection reported to the National Healthcare Safety Network (NHSN). Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter, which is a tube inserted into the bladder through the urethra to drain urine.  Between 15-25% of hospitalized patients receive urinary catheters during their hospital stay.  The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.

India Catheters Market- Key Players

Major players operating in the India catheters market include Abbott, Teleflex Incorporated, Boston Scientific Corporation or its affiliates, Coloplast Corp., Edwards Lifesciences Corporation, Johnson & Johnson Private Limited, Medtronic, B. Braun SE, Cook, BD (Becton, Dickinson and Company), Vygon, Cardinal Health, Smiths Group plc., Nipro Medical Corporation, and Argon Medical Devices.